Dr. Roopa Viswanathan, Study Director
Qualilife Diagnostics, India
Objective
To evaluate the efficacy of the Protect 200 / Nano on reducing Mycobacterium tuberculosis.
Methodology
The Protect 200 / Nano unit was placed inside a 68 litre plastic enclosure. The plastic enclosure and test set up was placed inside a biosafety cabinet. Clinical isolate of Mycobacterium tuberculosis was aseptically transferred into a sterile mycobacteria growth indicator tube (MGIT) and Lowenstein-Jensen (LJ) medium.
Summary of Results
The air sample collected from the test after being exposed to the Protect 200 / Nano showed no growth of Mycobacterium tuberculosis. This shows that the device has effectively rendered all airborne Mycobacterium tuberculosisnon-viable.
USA Headquarters
Stamford, Connecticut
Call: 1 866 508 1118 Email: info@wellairsolutions.com
Ireland Headquarters
DCU Innovation Campus Old Finglas Road Glasnevin, Dublin 11
Call: +353 1 907 2750 Email: info@wellairsolutions.com